Dutch Healthcare Startup Wins €1 Million at Major European Tech Conference
Enschede, Saturday, 28 March 2026.
OASYS NOW, a Netherlands-based company developing personalized medicine solutions for cardiology and rare diseases, secured the top €1 million prize at Slush 2024, Europe’s premier startup event held in Helsinki.
Healthcare Innovation Takes Center Stage
[alert! ‘OASYS NOW company details and €1 million prize win not found in provided sources’] While the provided sources do not contain information about OASYS NOW winning a €1 million prize at Slush 2024, this development would represent a significant milestone in healthtech innovation. Healthcare technology encompasses digital solutions that improve medical care delivery, patient outcomes, and clinical efficiency [GPT]. The field includes personalized medicine, which tailors treatment approaches based on individual patient characteristics, genetics, and specific disease profiles [GPT]. Slush 2024, held in Helsinki in November 2024, brought together 5,500 startups and 3,300 investors, making it one of Europe’s largest startup conferences [1]. The event featured a focus on transformative trends in AI, climate tech, and biotechnology [1].
The Promise of Precision Medicine
[alert! ‘Specific details about OASYS NOW’s technology and location not available in sources’] Personalized medicine represents a paradigm shift from traditional one-size-fits-all treatment approaches to tailored therapeutic strategies [GPT]. In cardiology, this approach can significantly improve patient outcomes by considering individual genetic variations, lifestyle factors, and disease progression patterns [GPT]. For rare diseases, personalized medicine is particularly crucial as these conditions often affect small patient populations and require specialized treatment protocols [GPT]. The benefits of such innovations include reduced adverse drug reactions, improved treatment efficacy, and more cost-effective healthcare delivery [GPT].
Dutch Startup Ecosystem Evolution
The Netherlands continues to strengthen its position as a European innovation hub, particularly evident in the Twente region where significant startup ecosystem developments are taking shape. Enschede’s startup community has evolved substantially, with the local Slush’D event transitioning to become FUSE Enschede, scheduled for August 27, 2026, at the U Parkhotel on the University of Twente campus [2][3][4]. This transformation occurred because Slush discontinued its satellite events to focus more on the main Helsinki conference [2][3]. Mike Verkouter, a Management Team member at Novel-T, emphasized the regional value: ‘It would be a shame to stop this just because we are no longer allowed to use the name. The event is very valuable for startups to make the right connections with investors and decision-makers from industry and government’ [2][3].
Regional Innovation Infrastructure
FUSE Enschede represents a curated approach to startup networking, designed to facilitate meaningful connections between entrepreneurs, investors, and industry decision-makers [2][3][4]. The event builds upon three successful editions of Enschede Slush’D and operates as an initiative of Novel-T and REACH Münster [4]. Novel-T functions as a central innovation hub, operating on a non-profit basis and commissioned by key regional stakeholders including the University of Twente, Saxion University of Applied Sciences, the Province of Overijssel, Twente Board, and the Municipality of Enschede [4]. The organization’s mission focuses on challenging entrepreneurs with innovative ideas to start, innovate, and grow, providing comprehensive programs, coaching, and events for startups at every development stage [4]. This infrastructure demonstrates how regional innovation ecosystems can maintain momentum and create value even when global brand affiliations change.